Osborne Clarke advises local and international life sciences businesses entering or expanding in the Belgian market. The team regularly handles product launches, complex regulatory compliance issues, aiming to facilitate cross-border growth. The team benefits from its strong international capabilities. Practice head Hadrien Chef specialises in M&A, venture capital and corporate matters across Belgium’s tech, pharma and biotech sectors, while Vladimir Murovec focuses exclusively on medical devices, pharmaceuticals and digital health regulation.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘The team has strong regulatory capabilities, stays abreast of recent developments, and they are lovely to work with. They are responsive and deliver high-quality work product.’
- ‘The team are strong collaborators. They are helpful and collegial, and I enjoy working with them.’
- ‘The life sciences team has strong technical knowledge with a very down-to-earth way of working. They’re quick to respond, clear in their advice, and good at finding practical or innovative solutions. They work well across borders with the other teams in Germany, Italy, France, Spain, the UK, etc.'
- ‘Vladimir Murovec gets things done, and you can count on him to deliver what’s needed without fuss. He has a very steady, calm professionalism that makes complex issues much easier to deal with. Vladimir’s advice is practical and relevant, and he’s completely reliable.’
Key clients
- Afflelou Group
- Amgen
- Founders of ATB Therapeutics
- Baxter (Vantive)
- Bepharbel Manufacturing
- BioSenic
- Bluefin Biomedicine, Inc.
- Chemviron
- Circular Innovation Fund
- CooperVision
- Danone
- Diageo
Work highlights
Advised the founders of ATB Therapeutics in securing €54 M in an equity round co-led by EQT Life Sciences and MRL Ventures Fund (MRLV), alongside contributions from V-Bio Ventures, VIVES Partners, the Belgian sovereign fund SFPIM, Wallonie Entreprendre, Sambrinvest, and other investors.
Provided IP advice to Exphar, a leading generics laboratory focused on developing accessible pharmaceutical products for the African market, in the structuring of a new supply chain.
Advised Samsara Vision, Inc. on EU-wide regulatory issues for supply chain and cross-border registrations, and provided multi-jurisdictional guidance on national rules for KOL engagement, tenders, clinical investigations, and consulting arrangements across Europe.
Lawyers
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Practice head
Hadrien Chef
Other key lawyers
Vladimir Murovec